Hematologic Malignancy
Myelodysplastic Syndrome with Low Blasts
CI-CAN-00003371MDS-LBExplore in graph →
Hematologic1 active trials
- NCIt
- C200389
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00003371MDS-LBExplore in graph →
Clinical trials
23 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00445744 | Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome | completed | N/A | 52 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 2, 2018 | clinicaltrials |
Data updated 22 days agoSource updated Jan 2, 2018source: clinicaltrials